| Date Filed | Type | Description |
| 05/17/2023 |
4
| Gullans Steven R. Ph.D. (Director) has filed a Form 4 on iSpecimen Inc.|
Txns:
| Granted 125 shares
@ $0 |
|
| 01/13/2023 |
4
| Gullans Steven R. Ph.D. (Director) has filed a Form 4 on iSpecimen Inc.|
Txns:
| Granted 10,000 options
@ $1.41, valued at
$14.1k
|
|
| 06/17/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2019 |
4
| Gullans Steven R. Ph.D. (President & CEO) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Granted 300,000 shares
@ $0 |
|
| 05/24/2018 |
4
| Gullans Steven R. Ph.D. (President & CEO) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Granted 50,000 options to buy
@ $5.56, valued at
$278k
|
|
| 02/12/2018 |
4
| Gullans Steven R. Ph.D. (Interim President & CEO) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Bought 71,429 shares
@ $7, valued at
$500k
|
|
| 01/30/2018 |
4
| Gullans Steven R. Ph.D. (Interim President & CEO) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Granted 60,000 options to buy
@ $10.44, valued at
$626.4k
|
|
| 07/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/28/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
| 05/31/2017 |
4
| Gullans Steven R. Ph.D. (Interim President & CEO) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Granted 60,000 options to buy
@ $10.26, valued at
$615.6k
|
|
| 03/14/2017 |
4
| Gullans Steven R. Ph.D. (Director) has filed a Form 4 on Gemphire Therapeutics Inc. |
| 08/12/2016 |
4
| Gullans Steven R. Ph.D. (Director) has filed a Form 4 on Gemphire Therapeutics Inc. |
| 08/08/2016 |
4
| Gullans Steven R. Ph.D. (Director) has filed a Form 4 on Gemphire Therapeutics Inc. |
| 08/04/2016 |
3
| Gullans Steven R. Ph.D. (Director) has filed a Form 3 on Gemphire Therapeutics Inc. |
| 06/16/2014 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/21/2014 |
4
| Gullans Steven R. Ph.D. (Director) has filed a Form 4 on TETRAPHASE PHARMACEUTICALS INC|
Txns:
| Bought 25,000 shares
@ $9.2391, valued at
$231k
|
|
| 03/27/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/19/2013 |
3
| Gullans Steven R. Ph.D. (10% Owner) has filed a Form 3 on TETRAPHASE PHARMACEUTICALS INC |